Received Mar 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (PRIORIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 4N222 | — |
Administration of only the liquid portion; Administration of only the liquid portion; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a patient who received MMR (Priorix) (batch number 4N222, expiry date 13-SEP-2026) for prophylaxis. In MAR-2025, the patient received Priorix. In MAR-2025, an unknown time after receiving Priorix, the patient experienced inappropriate preparation of medication (Verbatim: Administration of only the liquid portion) and inappropriate dose of vaccine administered (Verbatim: Administration of only the liquid portion). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 18-MAR-2025 The pharmacist reported that they had a new pharmacist here the other day, she think she gave the Priorix the new MMR, and she do not think she add it the stuff that was inside the little vial to it. The pharmacist think she only gave the syringe liquid which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The pharmacist mentioned that she was not sure that this was administer to a patient. The pharmacist mentioned that they just had the vaccine since 1 week ago, so in case that this was administer this happened just a few days ago.